Alamar Biosciences, Inc.

Contributing Author

Recent Articles by Alamar Biosciences, Inc.

3 hours	Alamar Biosciences NULISA Data Featured in More Than 140 Scientific Presentations at AAIC 2026, Highlighting Advances in Blood-Based Alzheimer's Biomarker Profiling ALMR GlobeNewswire
Jul-07	Alamar Biosciences Launches the First Multiplexed Blood-based Immunoassay for eMTBR-Tau, One of the Most Important Biomarkers in Alzheimer's Disease Research ALMR GlobeNewswire
May-08	Alamar Biosciences Reports First Quarter 2026 Financial Results ALMR GlobeNewswire
May-05	Alamar Biosciences to Participate in BofA Securities 2026 Healthcare Conference ALMR GlobeNewswire